Cardiovascular effects of romifidine in dogs

American Journal of Veterinary Research

Volumn 62, Issue 4, 2001, Pages 490-495

  Pypendop, Bruno H ^a,b   Verstegen, John P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROMIFIDINE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BODY TEMPERATURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CENTRAL VENOUS PRESSURE; DOG; DOSE RESPONSE; HEART INDEX; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; NONHUMAN; SEDATION; VASCULAR RESISTANCE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0035079794     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.490     Document Type: Article

References (21)

1. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
2. Hall LW, Clarke KW. Veterinary anesthesia. 9th ed. London: Bailliere Tindall, 1991;52-64.
3. England GC, Flack TE, Hollingworth E, et al. Sedative effects of romifidine in the dog. J Small Anim Pract 1996;37:19-25.
4. Lemke KA. Sedative effects of intramuscular administration of a low dose of romifidine in dogs. Am J Vet Res 1999;60:162-168.
5. England GC, Andrews F, Hammond RA. Romifidine as a premedicant to propofol induction and infusion anaesthesia in the dog. J Small Anim Pract 1996;37:79-83.
6. England GC, Hammond R. Dose-sparing effects of romifidine premedication for thiopentone and halothane anaesthesia in the dog. J Small Anim Pract 1997;38:141-146.
7. Klide AM, Calderwood HW, Soma LR. Cardiopulmonary effects of xylazine in dogs. Am J Vet Res 1975;36:931-935.
8. Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 1998;27: 612-622.
9. Pypendop B, Serteyn D, Verstegen J. Hemodynamic effects of medetomidine-midazolam-butorphanol and medetomidine-midazolam-buprenorphine combinations and reversibility by atipamezole in dogs. Am J Vet Res 1996;57:724-730.
10. Bergstrom K. Cardiovascular and pulmonary effects of a new sedative/analgesic (medetomidine) as a preanesthetic drug in the dog. Acta Vet Scand 1988;29:109-116.
11. Schmeling WT, Kampine JP, Roerig DL. et al. The effects of the stereoisomers of the alpha-2 adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology 1991;75:499-511.
12. Lentner G. Statistical methods. In: Lentner G, ed. Geigy scientific tables. Introduction to statistics, statistical tables and mathematical formulae. 8th ed. Basel, Switzerland: Ciba Geigy, 1982;199-203.
13. Xu H, Aibiki M, Seki K, et al. Effects of dexmedetomidine, an alpha2-adrenoceptor agonist, on renal sympathetic nerve activity, blood pressure, heart rate and central venous pressure in urethane-anesthetized rabbits, J Auton Nerv Syst 1998;71:48-54.
14. Gompf RE, Moise NS. Cardiovascular system. In: Bistner SI, Ford RB, eds. Kirk and Bistner's handbook of veterinary procedures and emergency treatment. 6th ed. Philadelphia: WB Saunders Co. 1995; 267-306.
15. Haskins SC, Patz JD, Farver TB. Xylazine and xylazine-ketamine in dogs. Am J Vet Res 1986;47:636-641.
16. Stoelting RK. Pulmonary circulation. In: Stoelting RK, ed. Pharmacology and physiology in anesthetic practice. 2nd ed. Philadelphia: JB Lippincott Co. 1991;685-691.
17. Darovic GO. Cardiovascular anatomy and physiology. In: Darovic GO, ed. Hemodynamic monitoring. Invasive and noninvasive clinical application. Philadelphia: WB Saunders Co, 1987;33-61.
18. Virtanen R. Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand 1989;85(suppl):29-37.
19. Haskins SC. Monitoring the anesthetized patient. In: Short CE, ed. Principles and practice of veterinary anesthesia. Baltimore: The Williams & Wilkins Co, 1987:455-477.
20. Vickery RG, Sheridan BC, Segal IS, et al. Anesthetic and hemodynamic effects of the stereoisomers of medetomidine, an alpha-2 adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg 1988;67:611-615.
21. Skrbic R, Chiba S. Pharmacological features of vascular responses of isolated dog and monkey lingual arteries to vasoactive substances. Jpn J Pharmacol 1991;57:99-107.